Evaluation of the Ability of Newly Developed Adhesives to Absorb Moisture
1 other identifier
interventional
6
1 country
1
Brief Summary
The aim of this evaluation is to investigate the ability of newly developed adhesive patches to absorb moisture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 4, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 4, 2018
CompletedFirst Submitted
Initial submission to the registry
July 13, 2018
CompletedFirst Posted
Study publicly available on registry
August 7, 2018
CompletedResults Posted
Study results publicly available
July 11, 2025
CompletedJuly 11, 2025
June 1, 2025
2 days
July 13, 2018
May 28, 2025
June 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Resistance (Moisture in the Adhesive)
The outcome measure is described as number of events where the sensor system reacted to a false positive leak. Moisture in adhesive is measured using a sensor system. Moisture influences the resistance of the sensor system. Intense moisture/sweat does not result in false positive leak signals. The signal response to moisture/sweat is different to the response to leaks.
3 days
Study Arms (1)
test patch
EXPERIMENTALtwo adhesive patches are applied to the abdominal area
Interventions
Eligibility Criteria
You may qualify if:
- Have given written informed consent
- Be at least 18 years of age and have full legal capacity
- Have intact skin on the area used in the evaluation
- Have an abdominal area accessible for application of test product (assessed by investigator)
- Negative pregnancy test for fertile women
- Signed document claiming use of safe contraceptives for fertile women
You may not qualify if:
- Currently receiving or have within the past 2 month received radio- and/or chemo-therapy
- Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
- Are pregnant or breastfeeding
- Having dermatological problems in the peristomal- or abdominal area (assessed by investigator)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Coloplast A/Slead
Study Sites (1)
Coloplast A/S
Humlebæk, 3050, Denmark
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Julie Schnipper, Medical Writer
- Organization
- Coloplast A/S
Study Officials
- PRINCIPAL INVESTIGATOR
Lene F Nielsen
Head of the pre-clinical department
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2018
First Posted
August 7, 2018
Study Start
July 2, 2018
Primary Completion
July 4, 2018
Study Completion
July 4, 2018
Last Updated
July 11, 2025
Results First Posted
July 11, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share